Novel Biomarkers of Dynamic Blood PD-L1 Expression for Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients

BACKGROUND: Immune checkpoint inhibitors (ICIs) have become a high-profile regimen for malignancy recently. However, only a small subpopulation obtains long-term clinical benefit. How to select optimal patients by reasonable biomarkers remains a hot topic. METHODS: Paired tissue samples and blood sa...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Immunol
Main Authors: Yang, Qiao, Chen, Mingjing, Gu, Jiaoyang, Niu, Kai, Zhao, Xianlan, Zheng, Linpeng, Xu, Zihan, Yu, Yongxin, Li, Feng, Meng, Lingxin, Chen, Zhengtang, Zhuo, Wenlei, Zhang, Luping, Sun, Jianguo
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2021
Assuntos:
Immunology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8085403/
https://ncbi.nlm.nih.gov/pubmed/33936103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.665133
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares